(Q55069380)

16 June 2018

title

MiR-335 inhibits migration of breast cancer cells through targeting oncoprotein c-Met. (English)

1 reference

16 June 2018

author name string

Yue Gao

1

1 reference

16 June 2018

Fan Zeng

2

1 reference

16 June 2018

Jia-Yan Wu

3

1 reference

16 June 2018

Hai-Yu Li

4

1 reference

16 June 2018

Jian-Jun Fan

5

1 reference

16 June 2018

Li Mai

6

1 reference

16 June 2018

Ji Zhang

7

1 reference

16 June 2018

Dong-Mei Ma

8

1 reference

16 June 2018

Yun Li

9

1 reference

16 June 2018

Fang-zhou Song

10

1 reference

16 June 2018

publication date

10 December 2014

1 reference

16 June 2018

published in

Tumor Biology

1 reference

16 June 2018

volume

36

1 reference

16 June 2018

issue

4

1 reference

16 June 2018

page(s)

2875-2883

1 reference

16 June 2018

cites work

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2917-6

Breast cancer metastasis: markers and models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2917-6

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2917-6

Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2917-6

MicroRNAs modulate hematopoietic lineage differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2917-6

Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2917-6

miR-15 and miR-16 induce apoptosis by targeting BCL2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2917-6

Oncomirs - microRNAs with a role in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2917-6

Endogenous human microRNAs that suppress breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2917-6

A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2917-6

Tumour invasion and metastasis initiated by microRNA-10b in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2917-6

Met, metastasis, motility and more

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2917-6

The MET receptor tyrosine kinase in invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2917-6

Involvement of c-Met/hepatocyte growth factor pathway in cholangiocarcinoma cell invasion and its therapeutic inhibition with small interfering RNA specific for c-Met

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2917-6

Downstream signalling and specific inhibition of c-MET/HGF pathway in small cell lung cancer: implications for tumour invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2917-6

miR-340 inhibition of breast cancer cell migration and invasion through targeting of oncoprotein c-Met

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2917-6

miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2917-6

miR-198 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the HGF/c-MET pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2917-6

Combinatorial microRNA target predictions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2917-6

Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2917-6

Epigenetic therapy of cancer with 5-aza-2'-deoxycytidine (decitabine).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2917-6

MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2917-6

Expression of the C-Met/HGF receptor in human breast carcinoma: Correlation with tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2917-6

Targeting the c-Met signaling pathway in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2917-6

Poor prognosis in breast carcinomas correlates with increased expression of targetable CD146 and c-Met and with proteomic basal-like phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2917-6

Targeting the HGF/Met signalling pathway in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2917-6

Phosphatidylinositol 3-kinase Contributes to Erk1/Erk2 MAP Kinase Activation Associated with Hepatocyte Growth Factor-induced Cell Scattering

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2917-6

Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET

21 January 2018

1 reference

12 December 2020

Hepatocytes and scatter factor

1 reference

12 December 2020

miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis

1 reference

12 December 2020

A hammerhead ribozyme suppresses expression of hepatocyte growth factor/scatter factor receptor c-MET and reduces migration and invasiveness of breast cancer cells

1 reference

12 December 2020

Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma

1 reference

12 December 2020

10.1007/S13277-014-2917-6

Identifiers

DOI

1 reference

16 June 2018

Dimensions Publication ID

1018043320

0 references

1 reference

16 June 2018